Reuters - Daily Investor Update

Click to View in Browser

Tuesday, October 17, 2017

Another round of NAFTA talks closes with little sign of agreement

WASHINGTON (Reuters) - Trade ministers from the United States, Canada and Mexico on Tuesday wrapped up a contentious round of NAFTA negotiations dominated by aggressive U.S. demands, including a sunset clause on the pact that Canadian and Mexican officials say will be rejected.

Mexico considers new laws on investor security if NAFTA dies: minister

WASHINGTON (Reuters) - Mexico is examining ways to create new laws that would give investors security over their investments if the NAFTA collapses, Mexico's economy minister said on Tuesday.

IBM reports marginal dip in quarterly revenue

(Reuters) - International Business Machines Corp's quarterly revenue slipped again as weak demand in the company's technology services business outweighed growth in its strategic areas that include cloud and security services.

Wall St. ends little changed; Dow brushes 23K milestone

NEW YORK (Reuters) - The Dow Jones Industrial Average briefly ticked above the 23,000 point mark for the first time on Tuesday, driven by strong earnings from UnitedHealth and Johnson & Johnson, though it finished the session just below that level.

Harvey Weinstein resigns from Weinstein Co board: source

LOS ANGELES (Reuters) - Harvey Weinstein has resigned from the board of The Weinstein Company, a source close to Weinstein said on Tuesday, as he faces allegations that he sexually harassed or assaulted a number of women over three decades in the film business.

Big U.S. stock exchanges ask SEC to hold off on fee cap plan

NEW YORK (Reuters) - A proposed regulatory experiment to test the effects of lowering stock exchange fees could end up making stocks harder to trade and should be delayed pending a comprehensive market review, the three largest U.S. stock exchange operators said in a letter to the Securities and Exchange Commission.

New cancer drugs help Johnson & Johnson top profit estimates

(Reuters) - Johnson & Johnson posted better-than-expected third-quarter earnings, raising its full-year forecast due to growth from new cancer drugs and high-margin treatments picked up in its $30 billion acquisition of Actelion earlier this year.

U.S. dollar up, yield curve flat, on inflation; stocks mixed

NEW YORK (Reuters) - U.S. stocks turned mixed on Tuesday on earnings reports, with the Down Jones Industrial Average breaching the 23,000 mark for the first time, while the U.S. Treasury yield curve flattened and the dollar rose to a one-week high on increased inflation expectations.

Powell likely next Fed chief, though Yellen best suited: economists

LONDON (Reuters) - Jerome Powell likely will be the next Federal Reserve chairman, according to a slim majority of economists in a Reuters poll - but most of them said current Fed Chair Janet Yellen would be the best option.

Trump likely to name Fed chair by early November: source

WASHINGTON (Reuters) - U.S. President Donald Trump has a pool of five candidates to choose from for the next chair of the Federal Reserve and is likely to announce his choice before going to Asia in early November, a source familiar with the situation said on Tuesday.